US Congressman welcomes India’s decision to resume export of surplus Covid vaccine

By: |
September 21, 2021 9:09 AM

India's Health Minister Mansukh Mandaviya on Monday said the country will resume export of surplus COVID-19 vaccines in the fourth quarter of this year under the 'Vaccine Maitri' programme to meet its commitment to the COVAX global pool.

covid 19 vaccines"I welcome today's announcement by the Government of India to resume COVID-19 vaccine exports," Congressman Gregory Meeks, the chairman of the powerful House Foreign Affairs Committee, said in a tweet on Monday. (Representational image)

An influential US Congressman has welcomed India’s decision to resume the export of surplus COVID-19 vaccines to meet its commitment to the COVAX global pool.

India’s Health Minister Mansukh Mandaviya on Monday said the country will resume export of surplus COVID-19 vaccines in the fourth quarter of this year under the ‘Vaccine Maitri’ programme to meet its commitment to the COVAX global pool. He, however, asserted that vaccinating own citizens remains the topmost priority of the government. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and WHO.

“I welcome today’s announcement by the Government of India to resume COVID-19 vaccine exports,” Congressman Gregory Meeks, the chairman of the powerful House Foreign Affairs Committee, said in a tweet on Monday.

“As the world’s leading vaccine manufacturer, India’s role is critical to defeating this pandemic,” Meeks tweeted tagging an article by The New York Times. India had stopped the export of COVID-19 vaccines after the second wave of the COVID-19 pandemic hit the country in April this year.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19: Kerala logs 9,445 new cases, 622 deaths
2COVID-19 virus test results may vary based on time of day: Study
3Merck agrees to let other drug makers make its COVID pill